Find participating medical centers and current study status in each of them

    Find participating medical centers

    A Study to Explore the Efficacy and Safety of Atezolizumab Plus Tiragolumab and Chemotherapy in 1st Line HER2 Negative Unresectable, Recurrent or Metastatic Gastric Cancer or Adenocarcinoma of Gastroesophageal Junction (GEJ)

    • Cancer
    • Gastric and Gastroesophageal Junction Carcinoma
    • Gastroesophageal Junction Adenocarcinoma
    • Gastric Cancer
    • Tumor
    • Neoplasms
    • Stomach Neoplasms